Analysis - The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until ...

Java defies the hype cycle, thriving at 30 with unmatched enterprise trust, modern AI integration, and a vibrant, global ...

With a strong foundation of technical progress and expanding geological potential across the 57 km² Ishkōday land package, LAURION is well-positioned for continued strategic interest. Shareholders are ...

Laurion Mineral Exploration Inc. is pleased to announce the successful analysis and completion of a 3D magnetotelluric inversion over the Ishk?day Project, a significant advancement in subsurface ...

Discover a study exploring cutting-edge melanoma vaccines and their potential to enhance long-term survival in high-risk patients.

OXB (formerly Oxford BioMedica), a listed gene and cell therapy firm, is anticipating strong growth in its latest half-year trading update.